<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010074825">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Segeral, O.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">N'Diaye, D. S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Prak, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Nouhin, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Chhun, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Khamduang, W.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Chim, K.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Roque-Afonso, A. M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Piola, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Borand, L.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Ngo-Giang-Huong, Nicole</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Rouet, F.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">ANRS Study Group</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study</title>
        <secondary-title>Journal of Clinical Virology</secondary-title>
      </titles>
      <pages>29-34</pages>
      <keywords>
        <keyword>Cambodia</keyword>
        <keyword>Hepatitis B virus</keyword>
        <keyword>Rapid diagnostic tests</keyword>
        <keyword>Pregnant women</keyword>
        <keyword>Mother-to-child transmission</keyword>
        <keyword>CAMBODGE</keyword>
      </keywords>
      <dates>
        <year>2018</year>
      </dates>
      <call-num>fdi:010074825</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Journal of Clinical Virology</full-title>
      </periodical>
      <isbn>1386-6532</isbn>
      <accession-num>ISI:000453568100006</accession-num>
      <electronic-resource-num>10.1016/j.jcv.2018.10.007</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010074825</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/2019/01/010074825.pdf</url>
        </pdf-urls>
      </urls>
      <volume>109</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Background: In Cambodia, access to hepatitis B surface antigen (HBsAg) screening is low for pregnant women and Hepatitis B Virus (HBV) DNA quantification is poorly accessible. Objectives: To evaluate the performance of a serial algorithm using two HBV rapid diagnostic tests (RDTs), in which samples positive for HBsAg were further tested for HBeAg as a surrogate marker for HBV DNA quantification. Study design: In 2015, we prospectively collected plasma samples from 250 pregnant women consulting for antenatal care in one hospital in Phnom Penh including 128 with a known positive HBsAg status. All specimens were tested with the SD BIOLINE HBsAg RDT and HBsAg ELISA assay. In ELISA-positive samples, HBeAg status was determined using the SD BIOLINE HBeAg RDT and HBV DNA quantification was assessed. Results: Sensitivity and specificity of HBsAg RDT were 99.2% (97.7-99.9) and 100% (97.0-100), respectively. Among the 128 ELISA-positive samples, 29 (23%) tested HBeAg positive and 34 (26.5%) had HBV DNA &gt; 5.3 Log(10) IU/mL. Sensitivity and specificity of HBeAg RDT in identifying viremic samples were 76.5% (62.2.0-90.7) and 96.8% (93.3-100) for HBV DNA &gt; 5.3 Log(10) IU/mL and 89.3% (77.8-100) and 96.0% (92.2-99.8) for HBV DNA &gt; 7.3 Log(10) IU/mL. Among the 99 negative HBeAg RDT women, 8 had HBV DNA &gt; 5.3 Log10 IU/mL and 7 of them harbored BCP/PC HBV mutants. Conclusions: A combination of HBsAg and HBeAg RDTs could be a low-cost strategy to identify HBV-infected pregnant women at risk of perinatal transmission in a country were HBV DNA quantification is not routinely available.</abstract>
      <custom6>052 ; 050</custom6>
      <custom1>UR174</custom1>
      <custom7>Cambodge / Thaïlande</custom7>
    </record>
  </records>
</xml>
